Sex‐associated differences between BMI and SARS‐CoV‐2 antibody titers following the BNT162b2 vaccine

…, A Tanaka, Y Oshiro, N Inamura, M Konishi, M Ozeki… - …, 2022 - Wiley Online Library
Objective This study investigated the sex‐associated difference in the impact of obesity on
antibody response to a COVID‐19 vaccine. Methods This study included 2,435 health care …

Coronavirus disease 2019 (COVID-19) breakthrough infection and post-vaccination neutralizing antibodies among healthcare workers in a referral hospital in Tokyo: a …

…, T Mizoue, M Konishi, M Ozeki… - Clinical Infectious …, 2022 - academic.oup.com
Background While increasing coverage of effective vaccines against coronavirus disease
2019 (COVID-19), emergent variants raise concerns about breakthrough infection. Data are …

[HTML][HTML] Durability and determinants of anti-SARS-CoV-2 spike antibodies following the second and third doses of mRNA COVID-19 vaccine

…, K Horii, K Okudera, M Konishi, M Ozeki… - Clinical Microbiology …, 2023 - Elsevier
Objectives To examine the differences in durability and its determinants of humoral immunity
following 2- and 3-dose COVID-19 vaccination. Methods Throughout the pandemic, we …

Seroprevalence of SARS-CoV-2 antibodies in a national hospital and affiliated facility after the second epidemic wave of Japan

…, M Ishii, H Ishiwari, M Konishi, K Matsuda, M Ozeki… - Journal of Infection, 2021 - Elsevier
Methods We invited all NCGM staff (Toyama and Kohnodai areas) and asked participants to
complete a questionnaire and donate venous blood in October (Toyama) and December (…

[HTML][HTML] Omicron BA. 1 neutralizing antibody response following Delta breakthrough infection compared with booster vaccination of BNT162b2

…, M Konishi, JS Takeuchi, K Horii, M Ozeki… - BMC Infectious …, 2023 - Springer
Background Longitudinal data are lacking to compare booster effects of Delta breakthrough
infection versus third vaccine dose on neutralizing antibodies (NAb) against Omicron. …

[HTML][HTML] Association of impaired fasting glucose and diabetes with SARS-CoV-2 spike antibody titers after the BNT162b2 vaccine among health care workers in a …

…, A Tanaka, Y Oshiro, N Inamura, M Konishi, M Ozeki… - Vaccines, 2022 - mdpi.com
Background: Hyperglycemia can alter the activation of innate and acquired immunity, but
epidemiological evidence linking hyperglycemia to post-vaccination immunogenicity is limited. …

[HTML][HTML] Neutralizing antibodies after three doses of the BNT162b2 vaccine, breakthrough infection, and symptoms during the Omicron-predominant wave

…, N Inamura, JS Takeuchi, M Konishi, M Ozeki… - International Journal of …, 2023 - Elsevier
Objectives To investigate the role of immunogenicity after the third vaccine dose against
Omicron infection and COVID-19-compatible symptoms of infection. Methods First, we examined …

Cumulative and undiagnosed SARS-CoV-2 infection among the staff of a medical research centre in Tokyo after the emergence of variants

…, K Horii, K Okudera, M Konishi, M Ozeki… - Epidemiology & …, 2023 - cambridge.org
To describe the trend of cumulative incidence of coronavirus disease 19 (COVID-19) and
undiagnosed cases over the pandemic through the emergence of severe acute respiratory …

[HTML][HTML] Sensitivity of anti-SARS-CoV-2 nucleocapsid protein antibody for breakthrough infections during the epidemic of the Omicron variants

…, Y Oshiro, N Inamura, T Nemoto, M Ozeki… - The Journal of …, 2022 - ncbi.nlm.nih.gov
Fig. 1. Setting of the restaurant.(A) Floor plan;(B) image obtained from the video camera. out
both close contact and fomite routes. In this specific context, we found that close contact …

Synovial mesenchymal stem cells promote meniscus regeneration augmented by an autologous Achilles tendon graft in a rat partial meniscus defect model

N Ozeki, T Muneta, S Matsuta, H Koga, Y Nakagawa… - Stem …, 2015 - academic.oup.com
Although meniscus defects and degeneration are strongly correlated with the later development
of osteoarthritis, the promise of regenerative medicine strategies is to prevent and/or …